Here, we further explored the qualities of the carboxy-terminal peptides CXCL447–70 and CXCL4L147–70 as anti-tumoral agents, more specifically against a human epidermal growth factor (EGF)-dependent tumor cell line, MDA-MB-231. Here, EGF is linked to neoplasm.